Between April 30, 2020 and February 24, 2022, certain CareDX insiders caused the company to issue false and misleading public statements regarding its compliance with health care laws and its purported revenue growth. However, beginning on October 28, 2021, CareDx made its first in a series of public disclosures announcing that the company was facing multiple government investigations and that CareDx's financial results were far lower than it had previously claimed. By the time the company made its final disclosure on November 3, 2022, the price of CareDx's shares had plummeted by over 77.22%. Current stockholders who have held their CareDx stock since at least January 2021, and still hold today are encouraged to contact Johnson Fistel to discuss their legal rights in this matter.